LEX-01

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLEX-01
Drug Alias Namenext generation gene therapy (LEXEO Therapeutics)oxidation-resistant anti-protease therapy (LEXEO Therapeutics)LEX-01
ClassificationBiologics
Mechanisms of ActionLeukocyte elastase inhibitorsAlpha-1-antiproteinase modulators
TargetsLeukocyte elastaseAlpha-1-antiproteinase
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLexeo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLexeo Therapeutics Inc
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A